111° West Capital is the healthcare enterprise-software investment brand of 111 West Capital LLC, SEC exempt reporting adviser CRD325776 / file802-127943, verified in its March31,2026 annual FormADV. Its own site describes a multi-stage approach to commercial-stage companies, with an investment team and operator network supporting healthcare software businesses. Public first-party statements and statutory filings identify physician investors Michael Matly and Andrew Brooks, investment-team affiliate Daniel Tully and finance affiliate Sarah Pennebaker; the minimalist public website does not publish a complete staff directory. Matly is the current statutory managing member; Brooks signed FundI’s2021 filing as managing member of its general partner. Verified issuer announcements identify participation in Codoxo’s AI healthcare payment-integrity financings; own professional posts also identify Arine, Cherry, KODEHealth, Canopy and Healia backing, without transferring the founders’ earlier Montreux or personal portfolios to the manager. FundI and FundII are distinct Delaware pooled vehicles, with separate named investment LLCs. Reported securities subscriptions are distinguished from offering targets, asset values and issuer tickets: FundII’s May27,2026 amendment reports119,645,000USD sold in an indefinite offering, not a confirmed final close. Three smaller2025 filings report their stated offerings fully sold. Missing public-directory coverage, three authentic portrait gaps and unverified current titles are explicit research gaps; no unnamed fund or exact issuer allocation is inferred.
Founded
—
Type
Venture capital
Funds6
111 West Capital AB LLC—$8M
Distinct statutory US pooled venture vehicle under 111° West Capital branding. The 2025 primary notice reports the stated USD 8,073,934 offering fully sold, zero remaining and 28 investors. The filing date is not assumed to be the exact economic closing day. Reported securities subscriptions are distinguished from GP or manager asset values and from company investment tickets. No allocation of a portfolio company check to this vehicle is inferred.
111 West Capital CB LLC—$4M
Distinct statutory US pooled venture vehicle under 111° West Capital branding. The 2025 primary notice reports the stated USD 4,195,000 offering fully sold, zero remaining and 22 investors. No exact economic closing day was independently verified. Reported securities subscriptions are distinguished from GP or manager asset values and from company investment tickets. No allocation of a portfolio company check to this vehicle is inferred.
111 West Capital CC LLC—$12M
Distinct statutory US pooled venture vehicle under 111° West Capital branding. The 2025 primary notice reports the stated USD 12,070,000 offering fully sold, zero remaining and 48 investors. Neither issuer ticket allocation nor the exact economic closing day is inferred. Reported securities subscriptions are distinguished from GP or manager asset values and from company investment tickets. No allocation of a portfolio company check to this vehicle is inferred.
111 West Capital CNB LLC——
Distinct statutory US pooled venture vehicle under 111° West Capital branding. The December 5, 2025 primary notice verifies a Delaware pooled venture LLC formed in 2025 and Michael Matly’s manager affiliation. Actual capital subscriptions and final close were not independently confirmed, so amount and date remain NULL. Reported securities subscriptions are distinguished from GP or manager asset values and from company investment tickets. No allocation of a portfolio company check to this vehicle is inferred.
111 West Capital Fund I LP——
Distinct statutory US pooled venture vehicle under 111° West Capital branding. The July 16, 2021 initial Form D states a USD 100 million target, zero sold and first sale yet to occur. The March 2026 ADV reports private vehicle 805-9847140043 and GP 111 West Capital GP I LLC. No actual final close was verified. Reported securities subscriptions are distinguished from GP or manager asset values and from company investment tickets. No allocation of a portfolio company check to this vehicle is inferred.
111 West Capital Fund II LP—$119M
Distinct statutory US pooled venture vehicle under 111° West Capital branding. The May 27, 2026 primary amendment reports USD 119,645,000 total sold to 116 investors in an indefinite offering, with first sale May 15, 2025. This is cumulative reported subscriptions, not a verified final close or fresh cash on the amendment date. Reported securities subscriptions are distinguished from GP or manager asset values and from company investment tickets. No allocation of a portfolio company check to this vehicle is inferred.
Michael MatlyCo-Founder and Managing Partner; statutory Managing Member
Codoxo$35M · 2025-12-17
CVS Health Ventures
Echo Health Ventures
GRA Venture Fund
Spider Capital
Wipro Ventures